Avivagen Inc. VIVXF
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0012 Day range 0.0012
0.0001 52-week range 0.0012
- YTD
- 0.00%
- 1 year
- 0.00%
News
defenseworld.net High Tide (NASDAQ:HITI) and Avivagen (OTCMKTS:VIVXF) Financial Comparison Avivagen (OTCMKTS:VIVXF - Get Free Report) and High Tide (NASDAQ: HITI - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the…
defenseworld.net Contrasting Avivagen (OTCMKTS:VIVXF) & Stryker (NYSE:SYK) Stryker (NYSE: SYK - Get Free Report) and Avivagen (OTCMKTS:VIVXF - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the…
newsfilecorp.com Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA Ottawa, Ontario--(Newsfile Corp. - April 24, 2024) - Avivagen Inc. (TSXV: VIV) ("Avivagen" or the "Company"), a life sciences corporation focused on developing and commercializing products for…
businesswire.com Avivagen Announces New 500Kg Order for OxC-beta™ OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion…
businesswire.com Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2023 OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human…
businesswire.com Avivagen Provides Corporate Updates OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion…
businesswire.com Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock Product OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion…
businesswire.com Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal…
businesswire.com Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2021 OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal…
businesswire.com Avivagen Announces Largest Single Customer Purchase Order OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal…
businesswire.com Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”) announces that a total of 3,931 common shares will be issued at the rate of $0.58 per share…
newsfilecorp.com Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast Phoenix, Arizona--(Newsfile Corp. - April 6, 2021) - The Stock Day Podcast welcomed Avivagen (OTCQB: VIVXF) ("the Company"), a life sciences corporation focused on developing and commercializing…benzinga.com Stocks That Hit 52-Week Highs On Tuesday
